Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2022 Filed Feb 9, 2023 22:18 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 127 | $236.01 | $29,973.27 |
DisclosureSEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 3 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870 Underlying: Common Stock · 127 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 28, 2022 Filed Feb 9, 2023 22:20 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 133 | $236.01 | $31,389.33 |
DisclosureSEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 3 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,494 Underlying: Common Stock · 133 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 28, 2022 Filed Feb 9, 2023 22:21 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 116 | $236.01 | $27,377.16 |
DisclosureSEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 3 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351 Underlying: Common Stock · 116 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:04 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000074 · wf-form4_165247573956603.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 25,339 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:03 UTC |
Burt CarolDirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000073 · wf-form4_165247567810499.xml · nonDerivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,899 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:14 UTC |
Stamps Sheila ADirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000078 · wf-form4_165247635478900.xml · nonDerivative · entry 1 Stamps Sheila A · CIK 0001600782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:05 UTC |
Rittenmeyer Ronald ADirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000076 · wf-form4_165247581647760.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,533 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:06 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000077 · wf-form4_165247585020750.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,180 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:05 UTC |
Wims Morris LeslieDirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000075 · wf-form4_165247576743276.xml · nonDerivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:02 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000072 · wf-form4_165247564402913.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,673 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 11, 2022 Filed Feb 9, 2023 22:18 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 136 | $200.96 | $27,330.56 |
DisclosureSEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 2 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743 Underlying: Common Stock · 136 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 11, 2022 Filed Feb 9, 2023 22:20 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 143 | $200.96 | $28,737.28 |
DisclosureSEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 2 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361 Underlying: Common Stock · 143 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 11, 2022 Filed Feb 9, 2023 22:21 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 131 | $200.96 | $26,325.76 |
DisclosureSEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 2 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:09 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 5,462 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000027 · wf-form4_164487653764987.xml · derivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,462 Underlying: Common Stock · 5,462 shares Expires 2032-02-10 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:09 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 1,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000027 · wf-form4_164487653764987.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,841 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:08 UTC |
Knightly Kevin CSee Remarks
|
GrantStock Appreciation Right · Derivative | 7,283 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000025 · wf-form4_164487646970481.xml · derivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,283 Underlying: Common Stock · 7,283 shares Expires 2032-02-10 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:08 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 1,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000025 · wf-form4_164487646970481.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,115 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:08 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 8,193 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · derivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,193 Underlying: Common Stock · 8,193 shares Expires 2032-02-10 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:08 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,218 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:07 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 76,472 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000023 · wf-form4_164487640620414.xml · derivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,472 Underlying: Common Stock · 76,472 shares Expires 2032-02-10 F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:07 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 20,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000023 · wf-form4_164487640620414.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,740 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:07 UTC |
Korakis Emmanuel NSee Remarks
|
GrantStock Appreciation Right · Derivative | 2,184 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000024 · wf-form4_164487643728959.xml · derivative · entry 2 Korakis Emmanuel N · CIK 0001449366 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184 Underlying: Common Stock · 2,184 shares Expires 2032-02-10 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:07 UTC |
Korakis Emmanuel NSee Remarks
|
GrantCommon Stock | 586 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000024 · wf-form4_164487643728959.xml · nonDerivative · entry 1 Korakis Emmanuel N · CIK 0001449366 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,932 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:06 UTC |
Bruehlman Ronald ESee Remarks
|
GrantStock Appreciation Right · Derivative | 21,849 | $0.00 Strike: $250.43 | $0.00 |
DisclosureSEC source: 0001478242-22-000022 · wf-form4_164487637172562.xml · derivative · entry 4 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,849 Underlying: Common Stock · 21,849 shares Expires 2032-02-10 F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:06 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000022 · wf-form4_164487637172562.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,224 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. Read SEC document |
| February 10, 2022 Filed Feb 9, 2023 22:18 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 110 | $250.43 | $27,547.30 |
DisclosureSEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607 Underlying: Common Stock · 110 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 10, 2022 Filed Feb 9, 2023 22:20 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 114 | $250.43 | $28,549.02 |
DisclosureSEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,218 Underlying: Common Stock · 114 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 10, 2022 Filed Feb 9, 2023 22:21 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 104 | $250.43 | $26,044.72 |
DisclosureSEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104 Underlying: Common Stock · 104 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:07 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 3,834 | $255.57 | $979,855.38 |
DisclosureSEC source: 0001478242-22-000019 · wf-form4_164461722537812.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,374 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:07 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 9,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000019 · wf-form4_164461722537812.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,208 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:08 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 705 | $255.57 | $180,176.85 |
DisclosureSEC source: 0001478242-22-000020 · wf-form4_164461729807520.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,342 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:06 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 50,039 | $255.57 | $12,788,467.23 |
DisclosureSEC source: 0001478242-22-000018 · wf-form4_164461717832344.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693,198 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:06 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 91,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000018 · wf-form4_164461717832344.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743,237 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:05 UTC |
Korakis Emmanuel NSee Remarks
|
Tax withholdingCommon Stock | 758 | $255.57 | $193,722.06 |
DisclosureSEC source: 0001478242-22-000017 · wf-form4_164461712356816.xml · nonDerivative · entry 2 Korakis Emmanuel N · CIK 0001449366 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,346 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:05 UTC |
Korakis Emmanuel NSee Remarks
|
GrantCommon Stock | 1,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000017 · wf-form4_164461712356816.xml · nonDerivative · entry 1 Korakis Emmanuel N · CIK 0001449366 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,104 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:04 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 3,961 | $255.57 | $1,012,312.77 |
DisclosureSEC source: 0001478242-22-000016 · wf-form4_164461707663923.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,159 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:04 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 9,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000016 · wf-form4_164461707663923.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,120 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:04 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 3,788 | $255.57 | $968,099.16 |
DisclosureSEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,018 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:04 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 9,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,806 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
PurchaseCommon Stock | 10,000 | $272.93 | $2,729,300.00 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · nonDerivative · entry 2 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,344 F3 · price: The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $270.67 to $274.52 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
GiftCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 14,344 F1 · price: 20,000 shares were donated to the Danhakl Family Foundation for no remuneration. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| December 03, 2021 Filed Feb 2, 2022 22:02 UTC |
Rittenmeyer Ronald ADirector
|
GiftCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000006 · wf-form5_164383930182791.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,538 Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:47 UTC |
CONNAUGHTON JOHNDirector
|
GiftCommon Stock | 7,865 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046835 · doc4.xml · nonDerivative · entry 2 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:47 UTC |
CONNAUGHTON JOHNDirector
|
OtherCommon Stock | 62,390 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046835 · doc4.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F3 · kind: On December 2, 2021, Integral 2008 distributed 62,390 shares of common stock to its partners, including 7,865 shares of common stock to Mr. Connaughton, in connection with certain charitable gifts made by such partners. F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Integral 2008. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to the shares of common stock held by Integral 2008. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 23:02 UTC |
CONNAUGHTON JOHNDirector
|
SaleCommon Stock | 555,094 | $262.60 | $145,767,684.40 |
DisclosureSEC source: 0000899243-21-046434 · doc4.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 62,390 F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| October 26, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 108 | $256.09 | $27,657.72 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · derivative · entry 6 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497 Underlying: Common Stock · 108 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| October 26, 2021 Filed Feb 2, 2022 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 113 | $256.09 | $28,938.17 |
DisclosureSEC source: 0001478242-22-000005 · wf-form5_164383923231572.xml · derivative · entry 4 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,104 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| October 25, 2021 Filed Feb 17, 2022 22:03 UTC |
Bruehlman Ronald ESee Remarks
|
SaleCommon Stock | 4 | $256.93 | $1,027.72 |
DisclosureSEC source: 0001478242-22-000043 · wf-form4_164513535199187.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,224 F1 · acquired: The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf. Read SEC document |
| September 23, 2021 Filed Feb 17, 2022 22:03 UTC |
Bruehlman Ronald ESee Remarks
|
PurchaseCommon Stock | 4 | $262.82 | $1,051.28 |
DisclosureSEC source: 0001478242-22-000043 · wf-form4_164513535199187.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,228 F1 · acquired: The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:00 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 6,055 | $250.00 | $1,513,750.00 |
DisclosureSEC source: 0001478242-21-000055 · wf-form4_162932042335219.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,006 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.